SAYDAM, F. Et Al. 2017. The CYP2C19*2 and CYP2C19*17 Polymorphisms play a Vital Role in Clopidogrel Responsiveness after Percutaneous Coronary Intervention: A Pharmacogenomics Study. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY , vol.121, no.1 , 29-36.

SAYDAM, F., DEĞİRMENCİ, İ., Birdane, A., ÖZDEMİR, M., ULUS, T., ÖZBAYER, C., ... ÇOLAK, E.(2017). The CYP2C19*2 and CYP2C19*17 Polymorphisms play a Vital Role in Clopidogrel Responsiveness after Percutaneous Coronary Intervention: A Pharmacogenomics Study. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY , vol.121, no.1, 29-36.

SAYDAM, FARUK Et Al. "The CYP2C19*2 and CYP2C19*17 Polymorphisms play a Vital Role in Clopidogrel Responsiveness after Percutaneous Coronary Intervention: A Pharmacogenomics Study," BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY , vol.121, no.1, 29-36, 2017

SAYDAM, FARUK Et Al. "The CYP2C19*2 and CYP2C19*17 Polymorphisms play a Vital Role in Clopidogrel Responsiveness after Percutaneous Coronary Intervention: A Pharmacogenomics Study." BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY , vol.121, no.1, pp.29-36, 2017

SAYDAM, F. Et Al. (2017) . "The CYP2C19*2 and CYP2C19*17 Polymorphisms play a Vital Role in Clopidogrel Responsiveness after Percutaneous Coronary Intervention: A Pharmacogenomics Study." BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY , vol.121, no.1, pp.29-36.

@article{article, author={FARUK SAYDAM Et Al. }, title={The CYP2C19*2 and CYP2C19*17 Polymorphisms play a Vital Role in Clopidogrel Responsiveness after Percutaneous Coronary Intervention: A Pharmacogenomics Study}, journal={BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY}, year=2017, pages={29-36} }